Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells

Background: Treatment of large bone defects due to trauma, tumor resection, or congenital abnormalities is challenging. Bone tissue engineering using mesenchymal stem cells (MSCs) represents a promising treatment option. However, the quantity and quality of engineered bone tissue are not sufficient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Groeneveldt, Lisanne C., Knuth, Callie, Witte-Bouma, Janneke, O’Brien, Fergal J., Wolvius, Eppo B., Farrell, Eric
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2014
Konular:
Bioengineering and Biotechnology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4151337/
https://ncbi.nlm.nih.gov/pubmed/25229057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2014.00029
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller